Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blind Procedures02:07

Blind Procedures

13.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.7K
Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A peripheral blood-based approach involving vimentin along with AURKA enabled efficient tracking of elusive Oct4/Sox2-expressing disseminated breast cancer stem cells.

Bioscience reports·2026
Same author

Exploring the socioeconomic pattern of humans' future orientation: A multimethod multistudy approach.

Journal of personality and social psychology·2026
Same author

International comparisons of survival after recurrent metastatic breast cancer in four countries: A population-based study.

Breast (Edinburgh, Scotland)·2026
Same author

Evaluation of an Artificial Intelligence Defined Lung Nodule Malignancy Score in Incidental Pulmonary Nodules: The CREATE Study.

Mayo Clinic proceedings. Digital health·2026
Same author

Performance across different versions of an artificial intelligence model for screen-reading of mammograms.

European radiology·2026
Same author

Aurora Kinase A inhibitor alisertib failed to exert its efficacy on TNBC cells due to consequential enrichment of polyploid giant cancer cells (PGCCs).

Discover oncology·2025

Related Experiment Video

Updated: Mar 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Anticipating anonymity in screening program databases.

Rafael Caballero1, Sagar Sen2, Jan F Nygård3

  • 1University Complutense of Madrid, Spain.

International Journal of Medical Informatics
|May 29, 2017
PubMed
Summary

This study introduces new algorithms to enhance participant privacy in screening programs by anonymizing appointment data. These methods improve data security for medical research while protecting individual identities.

Keywords:
AnonymityConstraint programmingScreening programs

More Related Videos

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
09:04

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

13.3K
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

15.0K

Related Experiment Videos

Last Updated: Mar 1, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
09:04

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

13.3K
Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
16:23

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction

Published on: February 26, 2014

15.0K

Area of Science:

  • Health Informatics
  • Medical Data Privacy
  • Algorithm Development

Background:

  • Screening program data, including appointment details, is vital for medical research and program improvement.
  • Combining screening data with quasi-identifiers (ZIP code, gender, age) risks participant identity disclosure.
  • Protecting participant privacy is crucial for the ethical and effective operation of screening programs.

Purpose of the Study:

  • To propose and evaluate novel algorithms for improving anonymity in screening program databases.
  • To enhance participant privacy by mitigating the risk of identity disclosure through anonymized datasets.
  • To introduce and apply the concept of generalized k-anonymity for measuring privacy levels.

Main Methods:

  • Development of two algorithms: an optimal one using constraint programming and a suboptimal heuristic algorithm for large datasets.
  • Implementation of algorithms to generate anonymized sets of screening appointments.
  • Utilizing generalized k-anonymity to quantify the achieved level of anonymity.

Main Results:

  • The proposed algorithms effectively increase the anonymity of screening program datasets.
  • Experiments with random and real-world data (Norwegian Cancer Registry) demonstrate the utility of the approach.
  • The heuristic algorithm provides a practical solution for anonymizing large-scale datasets.

Conclusions:

  • The developed techniques offer a robust solution for enhancing privacy in screening program data.
  • The generalized k-anonymity metric provides a valuable tool for assessing data anonymization effectiveness.
  • This work contributes to safer data sharing practices in medical research and program evaluation.